LAG-3 Hit II
Product Specifications
Target
LAG-3
Related Pathways
Immunology/Inflammation
Bioactivity
LAG-3Hit II is an inhibitor of LAG-3 with a KD of 4.32 μM. It is applicable in research related to cancers such as ovarian cancer, colon adenocarcinoma, and melanoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog